Tower Research Capital LLC (TRC) - RAPTOR PHARMACEUTICAL CORP ownership

RAPTOR PHARMACEUTICAL CORP's ticker is RPTP and the CUSIP is 75382F106. A total of 116 filers reported holding RAPTOR PHARMACEUTICAL CORP in Q3 2016. The put-call ratio across all filers is 0.50 and the average weighting 0.2%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of RAPTOR PHARMACEUTICAL CORP
ValueSharesWeighting
Q3 2016$4,000
+300.0%
447
+73.9%
0.00%
Q1 2016$1,000
-80.0%
257
-73.3%
0.00%
-100.0%
Q4 2015$5,000
+25.0%
963
+37.6%
0.00%
Q3 2015$4,000
-96.8%
700
-91.2%
0.00%
-100.0%
Q2 2015$126,000
-57.9%
7,953
-71.1%
0.01%
-70.3%
Q1 2015$299,000
+7375.0%
27,478
+6874.1%
0.04%
Q4 2014$4,000394
+7780.0%
0.00%
Q1 2014$0
-100.0%
5
-99.7%
0.00%
-100.0%
Q4 2013$23,000
-32.4%
1,758
-22.5%
0.00%0.0%
Q3 2013$34,0002,2680.00%
Other shareholders
RAPTOR PHARMACEUTICAL CORP shareholders Q3 2016
NameSharesValueWeighting ↓
Trellus Management Company, LLC 63,500$1,003,0001.13%
Broadfin Capital, LLC 1,319,883$20,841,0001.12%
BAILARD, INC. 160,000$2,526,0000.39%
Birchview Capital, LP 46,000$726,0000.38%
HIGHLAND CAPITAL MANAGEMENT LP 1,182,167$18,666,0000.38%
Rock Springs Capital Management LP 305,000$4,816,0000.35%
SPHERA FUNDS MANAGEMENT LTD. 206,500$3,261,0000.32%
GLOBEFLEX CAPITAL L P 109,771$1,733,0000.32%
GROUP ONE TRADING, L.P. 1,319,766$20,839,0000.29%
Perceptive Advisors 264,204$4,172,0000.25%
View complete list of RAPTOR PHARMACEUTICAL CORP shareholders